|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4458 | |
| A61K 31/435 | |||
| A61P 25/06 | |||
| A61P 25/08 | |||
| A61P 25/26 | |||
| A61P 25/28 | |||
| A61P 35/00 | |||
| A61P 25/00 | |||
| A61K 31/165 |
| (11) | Number of the document | 3024458 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14742249.7 |
| Date of filing the European patent application | 2014-07-24 | |
| (97) | Date of publication of the European application | 2016-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/065975 |
| Date | 2014-07-24 |
| (87) | Number | WO 2015/011246 |
| Date | 2015-01-29 |
| (30) | Number | Date | Country code |
| 13306074 | 2013-07-24 | EP |
| (72) |
MOUTHON, Franck, FR
CHARVERIAT, Mathieu, FR
|
| (73) |
Commissariat ą l`Énergie Atomique et aux Énergies Alternatives,
25, Rue Leblanc Bātiment "Le Ponant D", 75015 Paris,
FR
|
| (54) | USE OF FLECAINIDE AS AN ANTI-CONNEXIN AGENT AND METHOD FOR POTENTIATING THE EFFECTS OF A PSYCHOTROPIC DRUG |
| USE OF FLECAINIDE AS AN ANTI-CONNEXIN AGENT AND METHOD FOR POTENTIATING THE EFFECTS OF A PSYCHOTROPIC DRUG |